Not Medical Advice: A telehealth platform is not a substitute for ongoing primary care. GLP-1 medications require ongoing physician monitoring. Always inform your primary care provider when starting a GLP-1, even if obtained through telehealth.
Six Standards Every GLP-1 Provider Should Meet
GLP-1 medications are powerful prescription drugs with real risks. A responsible telehealth provider builds clinical safeguards into their workflow. Here's what we evaluate.
1. MD/DO Physician Oversight
The prescribing clinician should be a licensed Medical Doctor (MD) or Doctor of Osteopathic Medicine (DO) — not an AI form review. Nurse Practitioners (NPs) and Physician Assistants (PAs) can be excellent prescribers but should operate within a physician-supervised workflow. The prescriber must hold an active license in the patient's state.
2. Required Lab Work
Before starting a GLP-1, baseline labs should include: HbA1c, comprehensive metabolic panel (CMP), lipid panel, and TSH. Repeat labs at 3 and 6 months allow physicians to monitor metabolic response and detect early signs of pancreatitis or kidney injury. Providers that skip labs entirely are cutting corners on safety.
3. 503A Pharmacy Compounding
If receiving compounded semaglutide or tirzepatide, the source pharmacy must be a U.S.-licensed 503A facility operating under patient-specific prescription compounding rules. Quality providers use pharmacies that conduct independent third-party testing for potency, sterility, and endotoxin levels — and publish certificates of analysis on request.
4. Transparent, Predictable Pricing
Prices should not increase as your dose escalates. Many providers advertise a low entry price, then charge significantly more once you reach therapeutic doses (e.g., $200 for 0.25mg → $400 for 2.4mg). Look for flat-rate plans where the same monthly fee covers any dose. Hidden fees for prescriptions, lab orders, or shipping are red flags.
5. Continuity of Care
Quality providers offer follow-up appointments, message-based clinical access, dose adjustments, and side effect management — not just a one-time prescription mill. You should be able to reach a clinician quickly if you experience adverse effects, and the same clinician (or care team) should know your case over time.
6. Operational Transparency
Reputable providers publish their physician network, pharmacy partners, lab providers, and clinical protocols. They disclose ownership structure, telehealth board affiliations, and how they handle adverse events. Avoid platforms that hide who is prescribing your medication or where it's being compounded.
How We Rank Providers
Each provider receives a score out of 100, calculated from five weighted criteria. Scores are recalculated monthly based on verified pricing, published policies, and patient-reported feedback.
Selected Major U.S. GLP-1 Telehealth Providers
Each provider was evaluated on pricing transparency, pharmacy sourcing (503A/503B), physician oversight, and state availability. Pricing reflects entry-level monthly cost as verified May 2026. Methodology in full on our Methodologypage. NexLife is our editorial #1 pick — see our .
Green Flags vs Red Flags
- Require baseline labs before prescribing
- Use U.S.-licensed 503A pharmacies (not international)
- Publish their pharmacy partners openly
- Offer flat-rate pricing across all dose strengths
- Provide MD or DO clinical oversight, not AI-only intake
- Conduct or disclose third-party testing (potency, sterility)
- Allow easy clinician messaging for side effects
- Have a clear medical director and care team disclosed
- Offer transparent refund and cancellation policies
- Are licensed in your specific state
- Charge dramatically more for higher doses (1mg → 2.4mg)
- Won't disclose where the medication is compounded
- Skip baseline labs entirely
- Offer a prescription after a 60-second AI form
- Source from unlicensed or international pharmacies
- Have no MD on staff (only NPs operating without supervision)
- Make weight loss promises ("lose 30 lbs guaranteed")
- Charge surprise re-evaluation or "consultation" fees
- Don't provide a way to reach a clinician about side effects
- Lock you into a 6+ month contract with no exit
- Have FDA warning letters or pharmacy board sanctions
Editorial Disclosure: GLPOneReview.com may earn a flat referral fee from some providers when readers click through. The fee is identical regardless of provider, and our editorial team scores providers using a fixed algorithm — separated from referral data. Our scoring criteria are published above and have not changed since launch.
Disclosures Regarding Compounded GLP-1 Medications
FDA status of compounded medications. Several providers reviewed on this site facilitate access to compounded semaglutide or compounded tirzepatide. Compounded medications are not FDA-approved and have not been evaluated by the U.S. Food and Drug Administration for safety, effectiveness, or quality. Compounded semaglutide is not the same as Ozempic® or Wegovy®, and compounded tirzepatide is not the same as Mounjaro® or Zepbound®. None of the providers reviewed on this site are affiliated with Novo Nordisk or Eli Lilly.
Pharmacy sourcing. When prescribed by a licensed provider and clinically appropriate, compounded GLP-1 medications are typically prepared by U.S.-licensed compounding pharmacies operating under state board oversight and applicable sterile compounding standards, including USP <797>. Some formulations are sourced from FDA-registered 503B outsourcing facilities operating under current good manufacturing practices (cGMP); others are fulfilled by licensed 503A pharmacies based on provider direction, pharmacy availability, patient location, and applicable law. Product appearance, concentration, and packaging may vary by pharmacy.
Outcomes. Individual results vary. No provider reviewed on this site guarantees weight loss, treatment success, clinical outcomes, or medication eligibility. Outcomes depend on adherence, provider guidance, lifestyle changes, metabolic health, underlying conditions, and consistency with the care plan.
Service availability. Telehealth services are available only to individuals physically located in U.S. states where affiliated providers are licensed and pharmacy fulfillment is legally permitted. Service availability, medication access, consultation requirements, pharmacy options, and features may change based on regulatory and operational factors.